Global CRO Reach OPIS operates as a global clinical CRO with 18 country affiliates and experience managing Phase I-IV, interventional, non-interventional and medical device studies, presenting expansion opportunities for regional and cross-border clinical programs.

Therapeutic Breadth Strong expertise across oncology, cardiology, dermatology, neurology and multiple specialty areas including rare diseases and vaccines, enabling cross-sell into multiple therapeutic teams and expanding as clients diversify pipelines.

Full-Service Capabilities End-to-end trial support from concept to closure, with medical writing, biostatistics, regulatory and operations, positioning OPIS as a one-stop partner for sponsors seeking to streamline vendor management and speed to first patient in.

Data & Compliance Experience with data protection and privacy partnerships alongside ISO and RSS tech stacks, highlighting opportunities for clients prioritizing data governance, regulatory compliance, and secure trial data handling.

Mid-Market Focus With revenue in the 10–25 million range and a mid-size employee base, OPIS presents an attractive option for mid-market sponsors seeking specialized CRO capabilities without the overhead of large incumbents.